SNRS- Sunrise Technologies Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SNRS- Sunrise Technologies

SNRS 0.000001000

0.0%

Jun 6 11:01 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: MGV who wrote (4051)	11/12/2000 11:35:55 AM
From: RockDoc	Read Replies (1) of 4140

"Pay attention to their capacity to meet or exceed forecasts. I saw forecasts on this thread for as high as 70 machines sold and $15 million in revenue. It appears some of you wanted to believe that garbage. You all know it came in at 48 and $9 million. The stock has continued to decline because it is coming short of forecasts." I am doing exactly that. If you had followed ANY of the recent press releases or conference calls with SNRS, you would have been made aware that there were most certainly sales in the 3rd quarter that could not be recorded due to SEC requirements, and that will be recorded in the 4th quarter. You would have also read the Lehman Brothers report stating confidently that their projections for calendar year 2000 would be met by SNRS. They also reiterated a buy rating on SNRS with a target price of $19. You, the sophisticated, highly informed investor that you appear to be, know more than the average investor that a company like Lehman would not go out on a limb, especially in following a company BEFORE FINAL FDA APPROVAL (as they did with SNRS) with a strong buy rating. These guys are paid to be RIGHT. You know that. What are you frightened about? The company will announce sales and earnings over the next few quarters. It will become manifestly clearer whether or not the LTK technology is embraced by the market, and whether or not SNRS will execute it's business plan. The decline in SNRS's PPS on VERY LOW VOLUME during this "dead period" means nothing. You know it. I think your motives are quite transparent here. There is no way that you can state that SNRS will not meet or exceed all estimates of their sales and earnings for the next quarter and the most recent two quarters. It is already clear that SNRS will be the largest rollout in eye laser histroy, easily exceeding the number of laser sales by VISX in the first year following approval of their laser. You can take that to the bank, big guy. Wouldn't want to be short much longer on this one. Explosive upside potential. Will make it harder and harder for the 11 plus million shorts to exit in an orderly fashion when the street finally "gets it." So, pal. Put that in your pipe and smoke it. But don't inhale. RockDoc

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next